Anti-inflammatory activity of an ethanol extract of Caesalpinia sappan L. in LPS-induced RAW 264.7 cells

Journal of Food Science and Nutrition

Volumn 13, Issue 4, 2008, Pages 253-258

  Jeong, Il Yun ^a   Jin, Chang Hyun ^a   Park, Yong Dae ^a   Lee, Hyo Jung ^a   Choi, Dae Seong ^a   Byun, Myung Woo ^a   Kim, Yeung Ji ^b  

^a Korea Atomic Energy Research Institute   (South Korea)

^b Yeungnam College of Science and Technology   (South Korea)

Author keywords

Caesalpinia sappan; IL 6 (interleukin 6); iNOS (inducible nitric oxide synthase); NF B (nuclear factor kappa B); Nitric oxide

Indexed keywords

CAESALPINIA; CAESALPINIA SAPPAN;

EID: 81255135173     PISSN: 1226332X     EISSN: None     Source Type: Journal    
DOI: 10.3746/jfn.2008.13.4.253     Document Type: Article

References (22)

1. Safitri R, Tariqan P, Freisleben HJ, Rumampuk RJ, Murakami A. 2003. Antioxidant activity in vitro of two aromatic compounds from Caesalpinia sappan L. Biofactors 19: 71-77.
2. Kim EC, Hwang YS, Lee HJ, Lee SK, Park MH, Jeon BH, Jeon CD, Lee SK, Yu HH, You YO. 2005. Caesalpinia sappan induces cell death by increasing the expression of p53 and p21WAF1/CIP1 in head and neck cancer cells. Am J Chinese Med 33: 405-414.
3. Baek NI, Jeon SG, Ahn EM, Hahn JT, Bahn JH, Jang JS, Cho SW, Park JK, Choi SY. 2000. Anticonvulsant compounds from the wood of Caesalpinia sappan L. Arch Pharm Res 23: 344-348.
4. Oh SR, Kim DS, Lee IS, Jung KY, Lee JJ, Lee HK. 1998. Anticomplementary activity of constituents from the heartwood of Caesalpinia sappan. Planta Med 64: 456-458.
5. Bae IK, Min HY, Han AR, Seo EK, Lee SK. 2005. Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells. Eur J Pharmacol 513: 237-242.
6. Nathan C, Xie QW. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915-918.
7. Tamir S, Tannenbaum SR. 1996. The role of nitric oxide (NO) in the carcinogenic process. Biochim Biophys Acta 1288: F31-36.
8. Mordan LJ, Burnett TS, Zhang LX, Tom J, Cooney RV. 1993. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H10T1/2 fibroblasts. Carcinogenesis 14: 1555-1559.
9. Ohshima H, Bartsch H. 1994. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305: 253-264.
10. KrÖche KD, Fensel K, Kolb-bachofen V. 1998. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113: 147-156.
11. Paul PT, Gary SF. 2001. NF-κB: a key role in inflammatory diseases. J Clin Invest 107: 7-11.
12. Eigler A, Moeller J, Endres S. 1995. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine marcrophage cell line RAW 264.7. J Immunol 154: 4048-4054.
13. Hobbs AJ, Higgs A, Moncada S. 1999. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol 39: 191-220.
14. Calixoto JB, Campos MM, Otuki MF, Santos AR. 2004. Anti-inflammatory compounds of plant origin. Part III. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 70: 93-103.
15. Haddad JJ. 2002. Cytokines and related receptor-mediated signaling pathways. Biochem Biophys Res Commun 297: 700-713.
16. Feldmann M, Brennan FM, Maini R. 1998. Cytokines in autoimmune disorders. Int Rev Immunol 17: 217-228.
17. Nishimoto N. 2006. Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol 18: 277-281.
18. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM. 1992. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 90: 772- 779.
19. Bai XC, Lu D, Liu AL, Zhang ZM, Li XM, Zou ZP, Zeng WS, Cheng BL, Luo SQ. 2005. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 280: 17497-17506.
20. Dhar A, Young MR, Colburn NH. 2002. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 234-235: 185-193.
21. Sasaki Y, Hosokawa T, Nagai M, Nagumo S. 2007. In vitro study for inhibition of NO production about constituents of Sappan Lignum. Biol Pharm Bull 30: 193- 196.
22. Fu LC, Huang XA, Lai ZY, Hu YJ, Liu HJ, Cai XL. 2008. A new 3-benzylchroman derivative from Sappan Lignum (Caesalpinia sappan). Molecules 13: 1923-1930.